Search research articles
Contact Us
Filters
Showing results (401-410 of 409) with videos related to
Page
of 41
Sort By:
You have reached the last page of results.
This site can display upto 409 results.
Cell Reports
|
May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Cell Reports
|
October 6, 2017
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts
Max Nobis, David Herrmann, Sean C Warren, et al.
Science Advances
|
September 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status
Kendelle J Murphy, Daniel A Reed, Claire Vennin, et al.
Science Translational Medicine
|
April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Claire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Metabolism
|
August 14, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
Johan Vande Voorde, Rory T Steven, Arafath K Najumudeen, et al.
Gastroenterology
|
October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
Stephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Science Advances
|
July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Brooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Gastroenterology
|
November 19, 2016
Hypermutation In Pancreatic Cancer
Jeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature
|
February 25, 2016
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey, David K Chang, Katia Nones, et al.
Page
of 41
Search research articles
Search
Showing results (401-410 of 409) with videos related to
Sort By:
Page
of 41
You have reached the last page of results.
This site can display upto 409 results.
Cell Reports
|
May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Cell Reports
|
October 6, 2017
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts
Max Nobis, David Herrmann, Sean C Warren, et al.
Science Advances
|
September 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status
Kendelle J Murphy, Daniel A Reed, Claire Vennin, et al.
Science Translational Medicine
|
April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Claire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Metabolism
|
August 14, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
Johan Vande Voorde, Rory T Steven, Arafath K Najumudeen, et al.
Gastroenterology
|
October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
Stephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Science Advances
|
July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Brooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Gastroenterology
|
November 19, 2016
Hypermutation In Pancreatic Cancer
Jeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature
|
February 25, 2016
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey, David K Chang, Katia Nones, et al.
Page
of 41